The discovery of coregulators and other recent advances in our understanding of the molecular biology of nuclear receptor action have generated expectations that these exciting basic advances will ...
The VDR is a member of the steroid/hormone nuclear receptor superfamily that includes 48 ligand-activated transcription factors. [3] These factors bind to conserved elements in the promoters of ...
Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies ...
The osteoprotegerin–RANKL (receptor activator of nuclear factor κB ligand ... vitamin D, parathyroid hormone and bone turnover. A new study published in Osteoporosis International reveals ...